ULTRASTRUCTURAL STUDY OF THE EFFECT OF ZINC OXIDE NANOPARTICLES ON RAT PAROTID SALIVARY GLANDS AND THE PROTECTIVE ROLE OF QUERCETIN | ||||
| Alexandria Dental Journal | ||||
| Article 2, Volume 41, Issue 3, December 2016, Page 232-237 PDF (1006.2 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/adjalexu.2016.58053 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Sara A. Hamza1; Hanaa M. Aly2; Samia O. Soliman2; Dina M. Abdallah3 | ||||
| 1Assistant lecturer of Oral Biology – Faculty of Dentistry – Alexandria University | ||||
| 2Professor of Oral Biology – Faculty of Dentistry – Alexandria University | ||||
| 3Assistant Professor of General Pathology – Faculty of Medicine – Alexandria University. | ||||
| Abstract | ||||
| INTRODUCTION: Nanotechnology is the technology of diagnosing, treating, and preventing diseases using nanoscale structured materials. Zinc oxide nanoparticles (ZnO NPs) have useful effects for their less environmental hazards and for their application usages: tooth pastes, biomedicine and food as zinc supplements. On the other hand, ZnO NPs have toxic effect due to their tissue accumulation ability. Quercetin (Qc) is an antioxidant, categorized as a flavonol. Its beneficial effects are attributed to its phenolic hydroxyl groups. It has antioxidant and antiinflammatory activities. OBJECTIVES: To evaluate the effect of ZnO NPs on rat parotid salivary glands and to investigate the possible protective role of Qc. MATERIALS AND METHODS: Twenty-four adult male albino rats were divided into three equal groups: group (I) control, group (II) received ZnO NPs 300 mg/kg and group (III) received ZnO NPs 300 mg/kg + Qc 200 mg/kg for 28 days. At the end of the experiment, animals were euthanized and the parotid glands were dissected out. The effect of ZnO NPs on the parotid glands as well as the protective role of Qc were assessed by transmission electron microscopy. RESULTS: In group(II) the acinar cells showed signs of toxicity as apoptotic nuclei, degenerated mitochondria, dilated rough endoplasmic reticulum and vacuolization in the cytoplasm. Group (III) parotid glands exhibited remarkable improvement in the ultrastructure of their acinar cells and duct system. This appearance was near to that of control group. CONCLUSIONS: The study proved ZnO NPs toxicity and revealed that oral administration of Qc effectively prevented the toxicity associated with ZnO NPs administration in rat models. Thus, Qc might be used as a prophylactic treatment to prevent ZnO NPs toxicity. | ||||
| Keywords | ||||
| Zinc Oxide Nanoparticles; Quercetin; Parotid Salivary Glands | ||||
| References | ||||
|
1. Biskos G, Schmidt-Ott A. Airborne engineered nanoparticles: potential risks and monitoring challenges for assessing their impacts on children. Pediatric Respir. Rev. 2012; 13:79-83. 2. EspitiaP,SoaresN,CoimbraJ,JosédeAndradeN,CruzR, Medeiros E. Zinc Oxide Nanoparticles: Synthesis, Antimicrobial Activity and Food Packaging Applications. Food Bioprocess Technol. 2012; 5:1447-64. 3. Baek M, Chung HE, Yu J, Lee JA, Kim TH, Oh JM, et al. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. International Journal of Nanomedecine. 2012; 7:3081-97. 4. Niu, L.N., Fang M, Jiao K, Tang LH, Xiao YH, et al. Tetrapod-like zinc oxide whisker enhancement of resin composite. J Dent Res. 2010; 89:746-50. 5. De Sá JS, Moreira DC, Louvera Silva KA, Morgano MA, Quintaes KD. Consumption of oral hospital diets and percent adequacy of minerals in oncology patients as an indicative for the use of oral supplements. Clin. Nutr. 2014;33:655-61 . 6. Guan R, Kang T, Lu F, Zhang Z, Shen H, Liu M. Cytotoxicity, oxidative stress, and genotoxicity in human hepatocyte and embryonic kidney cells exposed to ZnO nanoparticles. Nanoscale Res Lett. 2012; 7:602. 7. Jennifer M, Maciej W. Nanoparticle Technology as a Double-Edged Sword: Cytotoxic, Genotoxic and Epigenetic Effects on Living Cells. Journal of Biomaterials and Nano biotechnology. 2013; 4:53-63 8. Hagens WI, Oomen AG, De Jong WH, Cassee FR, Sips AJ. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol. 2007; 49:217–29. 9. Lanone S, Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med. 2006; 6:651–63. 10. Vandebriel RJ, De Jong WH. A review of mammalian toxicity of ZnO nanoparticles. Nanotechnol. Sci. and Appl. 2012; 5:61-71. 11. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007; 9:49–89. 12. Wang B, Feng W, Wang M, Wang TC, Gu Y, Motao Z, et al. Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice. J Nanopart Res. 2008; 10:263–76. 13. Kelly G. Quercetin Monograph. Alternative Medicine Review. 2011; 16:172-3. 14.Verma R, Kushwah L, Gohel D, Patel M, Marvania T, Balakrishnan S. Evaluating the Ameliorative Potential of Quercetin against the Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats. Pulmonary Medicine. 2013; 2013:10. 15. Pasupuleti S, Alapati S, Ganapathy S, Anumolu G, Pully NR, Prakhya BM. Toxicity of zinc oxide nanoparticles through oral route. Toxicol Ind Health. 2012; 28:675-86. 16. ChungHEJ,BaekYuM,LeeJA,KimMS,KimSH, Maeng E H, et al. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomedicine. 2012; 7:3081-97. 17. Faddah LM, Abdel Baky NA, Al-Rasheed NM, Fatani AJ, Atteya M. Role of quercetin and arginine in ameliorating nano zinc oxide-induced nephrotoxicity in rats. BMC Complement Altern Med. 2012; 12:60. 18.Fawcett DW. Bloom and Fawcett: A Textbook of Histology. 12th ed. New York: Chapman and Hall; 1998:769-804. 19. Cormack DH. Essential Histology. Philadelphia: Lippincott Williams & Wilkins; 2001. 20. Kirkpatrick LA, Feeney BC. A simple guide to IBM SPSS statistics for version 20.0. Student ed. Belmont, Calif.: Wadsworth, Cengage Learning; 2013. 21.Moezzi A, McDonagh AM, Cortie MB. Zinc oxide particles: synthesis, properties and applications. Chem Eng J. 2012; 185:1-22. 22. Pasupuleti S, Alapati S, Ganapathy S, Anumolu G, Pully NR, Prakhya BM. Toxicity of zinc oxide nanoparticles through oral route. Toxicol Ind Health. 2012; 28:675-86. 23. Sharma V, Singh P, Pandey AK, Dhawan A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat Res. 2012; 745:84-91. 24.Vandebriel RJ, De Jong WH. A review of mammalian toxicity of ZnO nanoparticles. Nanotechnol Sci Appl. 2012; 5:61-71. 25. Chung HE, Yu J, Baek M, Lee JA, Kim MS, Kim SH, et al. Toxicokinetics of zinc oxide nanoparticles in rats. J Phys Conf Ser. 2013; 429: 1-7. 26. Al-Rasheed NM, Faddah LM, Mohamed AM, Abdel Baky NA, Mohammad RA. Potential impact of quercetin and idebenone against immuno-inflammatory and oxiditive renal damage induced in rats by titanium dioxide nanoparticles toxicity. J Oleo Sci. 2013; 62:961-71. 27. Xia T, Kovochich M, Liong M, Mädler L, Gilbert B, Shi H, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008; 2:2121-34. 28. Müller KH, Kulkarni J, Motskin M, Goode A, Winship P, Skepper JN, et al. pH-dependent toxicity of high aspect ratio ZnO nanowires in macrophages due to intracellular dissolution. ACS Nano. 2010; 4:6767-79. 29. Kao YY, Chen YC, Cheng TJ, Chiung YM, Liu PS. Zinc oxide nanoparticles interfere with zinc ion homeostasis to cause cytotoxicity. Toxicol Sci. 2012; 125:462-72. 30. Chang YN, Zhang M, Xia L, Zhang J, Xing G. The toxic effects and mechanisms of CuO and ZnO nanoparticles. Materials. 2012; 5:2850-71. 31. Thakur M, Gupta H, Singh D, Mohanty IR, Maheswari U, Vanage G, et al. Histopathological and ultra-structural effects of nanoparticles on rat testis following 90 days (Chronic study) of repeated oral administration. J Nanobiotechnol. 2014; 12:42 32. Iavicoli I, Fontana L, Leso V, Bergamaschi A. The effects of nanomaterials as endocrine disruptors. Int J Mol Sci. 2013; 14:16732-801. 33.Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran pathologic basis of disease. New York: Elsevier Health Sciences; 2014, 1-30. 34. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585:325-37. 35.Muthukumaran S, Sudheer AR, Menon VP, Nalini N. Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats. Toxicology. 2008; 243:207-15. 36. Joskova M, Franova S, Sadlonova V. Acute bronchodilator effect of quercetin in experimental allergic asthma. Bratisl Lek Listy. 2011; 112:9-12. 37.Prabu SM, Muthumani M, Shagirtha K. Quercetin potentially attenuates cadmium induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats. Eur Rev Med Pharmacol Sci. 2013; 17:582-95. 38.Prince PS, Sathya B. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. Eur J Pharmacol. 2010; 635:142–8. 39.Azevedo MI, Pereira AF, Nogueira RB, Rolim FE, Brito GA, Wong DVT, et al. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Mol Pain. 2013; 9:53. 40. Dong YS, Wang JL, Feng DY, Qin HZ, Wen H, Yin ZM, et al. Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int J Med Sci. 2014; 11:282 | ||||
|
Statistics Article View: 307 PDF Download: 698 |
||||
